Alivus Life Sciences (BOM:543322) EPS (Basic): ₹45.99 (TTM As of Mar. 2026)


BOM:543322 Alivus Life Sciences Ltd BOM:543322
83 GF Score
Price ₹1,106.75
GF Value ₹1,011.05
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Alivus Life Sciences EPS (Basic)?

Alivus Life Sciences BOM:543322 -0.84% 83 EPS (Basic) is ₹45.99 as of Mar. 2026. GuruFocus rates BOM:543322 with a GF Score™ of 83/100 and a GF Value™ of ₹1,011.05 (Fairly Valued). The stock has 3 warning signs investors should review.

Alivus Life Sciences's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ₹13.23. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹45.99.

Alivus Life Sciences's EPS (Diluted) for the three months ended in Mar. 2026 was ₹13.22. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹45.90.

Alivus Life Sciences's EPS without NRI for the three months ended in Mar. 2026 was ₹13.22. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 47.48.

During the past 12 months, Alivus Life Sciences's average EPS without NRIGrowth Rate was 20.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was 7.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 8.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, Alivus Life Sciences's highest 3-Year average EPS without NRI Growth Rate was 14.20% per year. The lowest was 3.50% per year. And the median was 10.20% per year.

Alivus Life Sciences  (BOM:543322) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Alivus Life Sciences EPS (Basic) Related Terms

Alivus Life Sciences EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Alivus Life Sciences's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alivus Life Sciences EPS (Basic) Chart

Alivus Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial 35.63 38.11 38.43 39.63 45.99

Alivus Life Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.57 9.91 10.60 12.25 13.23
BOM:543322
83GF Score
Alivus Life Sciences Ltd BOM:543322
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alivus Life Sciences EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Alivus Life Sciences's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(5644.83-0)/122.740
=45.99

Alivus Life Sciences's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(1626.61-0)/122.949
=13.23

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹45.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹45.99 mean?
Alivus Life Sciences (BOM:543322) has a EPS (Basic) of ₹45.99 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Alivus Life Sciences and its competitors.
Is Alivus Life Sciences' EPS (Basic) too high?
Alivus Life Sciences' current EPS (Basic) is ₹45.99. Overall, Alivus Life Sciences has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Alivus Life Sciences' EPS (Basic) compare to ZTS?
Alivus Life Sciences' EPS (Basic) of ₹45.99 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Alivus Life Sciences and its competitors. Alivus Life Sciences's current EPS (Basic) is ₹45.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alivus Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, Alivus Life Sciences (BOM:543322) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,011.05, compared to a current price of ₹1,106.75 — trading 9.5% above its estimated fair value. The current EPS (Basic) is ₹45.99. Alivus Life Sciences' overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Alivus Life Sciences (BOM:543322), the current EPS (Basic) is ₹45.99 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alivus Life Sciences (BOM:543322) Overvalued in 2026?

Based on GuruFocus' analysis, Alivus Life Sciences stock appears to be overvalued. The current stock price of ₹1,106.75 is trading 9.5% above its estimated GF Value™ of ₹1,011.05. GuruFocus considers Alivus Life Sciences to be Fairly Valued.

Key valuation signals for BOM:543322:

  • EPS (Basic): ₹45.99
  • GF Value™: ₹1,011.05 vs. price of ₹1,106.75 (9.5% above fair value)
  • GF Score™: 83/100 with 3 warning signs

No single metric tells the full story. See the BOM:543322 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alivus Life Sciences Business Description

Other Exchanges ALIVUS:India
Address 470, Cardinal Gracious Road, 4th Floor, OIA House, Andheri (East), Mumbai, MH, IND, 400 099
Alivus Life Sciences Ltd develops, manufactures, and supplies high-quality active pharmaceutical ingredients for cardiovascular disease, central nervous system disorders, pain management, diabetes, urology, gastrointestinal disorders, and other therapeutic areas.
83GF Score

Get the complete analysis for BOM:543322

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,106.75
Price
₹1,011.05
GF Value